UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050538
Receipt number R000057555
Scientific Title Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study
Date of disclosure of the study information 2023/03/08
Last modified on 2024/02/10 09:31:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study

Acronym

JSTM-PROS01HR

Scientific Title

Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study

Scientific Title:Acronym

JSTM-PROS01HR

Region

Japan


Condition

Condition

Prostate cancer

Classification by specialty

Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine treatment efficacy, adverse events, and heating feasibility in hyperthermia combined radiotherapy for high-risk prostate cancer through a multicenter prospective registry of patient data.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

5-year biochemical recurrence-free survival rate

Key secondary outcomes

3/5/8-year overall/cause-specific /clinical recurrence-free survival rate, Adverse event rate, Transitions in the IPSS and QOL scores


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1) Patients diagnosed with high-risk prostate cancer
2) Patients undergoing radiotherapy and hyperthermia
3) Patients who are 20 years of age or older at the time of enrollment
4) Patients with an ECOG Performance Status (PS) of 0 to 2
5) Patients expected to survive more than 3 months

Key exclusion criteria

1) Patients with multiple cancers (simultaneous multiple cancers or iatrogenic multiple cancers with a disease-free interval of 5 years or less).However, intraepithelial cancer, lesions equivalent to intramucosal cancer, and skin cancer are not included in overlapping cancers.
2) Patients who have a history of irradiation (re-irradiation) at the same site as the current irradiation.
3) Patients who will be treated with three-dimensional source body irradiation
4) Patients who will not receive concomitant endocrine therapy
5) Patients who are scheduled to receive concomitant small source radiation therapy
6) Patients who are judged by the principal investigator to be inappropriate for enrollment in this study.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Ito

Organization

Aichi Medical University Hospital

Division name

Radiology

Zip code

480-1103

Address

1-1 Yazako-Karimata, Nagakute, Aichi

TEL

0561-62-3311

Email

itou.makoto.292@mail.aichi-med-u.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Ito

Organization

Aichi Medical University Hospital

Division name

Radiology

Zip code

480-1103

Address

1-1 Yazako-Karimata, Nagakute, Aichi

TEL

0561-62-3311

Homepage URL


Email

itou.makoto.292@mail.aichi-med-u.ac.jp


Sponsor or person

Institute

Aichi Medical University

Institute

Department

Personal name

Makoto Ito


Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aichi Medical University /Faculty of Medicine Ethics Committee

Address

1-1 Yazako-Karimata, Nagakute, Aichi

Tel

0561-62-3311

Email

amu_ethics@aichi-med-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学病院(愛知県)/ Aichi Medical University Hospital(Aichi)
群馬大学数理データ科学教育研究センター (群馬県)/ Gunma University Center for Mathematics and Data Science (Gunma)
産業医科大学病院(福岡県)/ University of Occupational and Environmental Health(Fukuoka)
弘前大学医学部附属病院 (青森県)/ Hirosaki University Hospital (Aomori)
名古屋市立大学病院(愛知県)/ Nagoya City University Hospital (Aichi)
久留米大学病院(福岡県)/ Kurume University Hospital(Fukuoka)
総合大雄会病院(愛知県)/ Daiyukai General Hospital(Aichi)
厚生連高岡病院(富山県)/ Kouseiren Takaoka Hospital(Toyama)
総合南東北病院/南東北がん陽子線治療センター(福島県)/Southern Tohoku General Hospital/Southern Tohoku Proton Therapy Center


Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 12 Month 26 Day

Date of IRB

2023 Year 02 Month 06 Day

Anticipated trial start date

2023 Year 03 Month 08 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2023 Year 03 Month 08 Day

Last modified on

2024 Year 02 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057555